Drug intelligence / Profile preview

8-bromo-cyclic AMP

Development stage
Unknown
Modality
Small Molecules
Administration
Intramuscular, Intranasal, Intradermal, Oral, Parenteral
01

Overview

8-bromo-cyclic AMP (8-Br-cAMP) is a cell-permeable, metabolically stable analog of the intracellular second messenger cyclic adenosine monophosphate (cAMP). It acts as a potent agonist for cAMP-dependent protein kinase (PKA) and the exchange protein directly activated by cAMP (Epac). The substitution of a bromine atom at the 8-position of the adenine ring renders the molecule significantly more resistant to hydrolysis by cyclic nucleotide phosphodiesterases (PDEs) compared to endogenous cAMP, allowing for sustained activation of downstream signaling cascades. In experimental biology, 8-Br-cAMP is widely used to investigate the role of cAMP in diverse physiological processes, including the modulation of ion channels (such as HCN and BK channels), regulation of gene expression via CREB phosphorylation, and the control of cellular functions like decidualization, insulin secretion, and smooth muscle relaxation.

Other names
8-bromoadenosine 3',5'-cyclic monophosphate8-bromo-cAMP
02

Targets

EPAC1 (Rap guanine nucleotide exchange factor 3)EPAC2 (Rap guanine nucleotide exchange factor 4)PKA (Cyclic amp-dependent protein kinase)

Beyond the preview

Go deeper on 8-bromo-cyclic AMP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 8-bromo-cyclic AMP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call